<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-036748</identifier>
<setSpec>1138-7262</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Hypericum perforatum: just another herb?</dc:title>
<dc:description xml:lang="en">Hypericum is one of the best known herbs in our setting.    Hypericum perforatum (commonly called St    John´s wort) was first used as an anti-inflammatory    agent to treat skin lesions. At present, it has multiple    uses (as an antidepressant, for insomnia, as an anti-anxiety    drug, or as previously mentioned, an anti-inflammatory,    etc.), not all of which are officially accepted.    &#149; As regards its efficacy, there are some published clinical    trials showing the superiority of some hypericum extracts    as compared to placebo in the short-term treatment    of mild to moderate depression. Some clinical    trials also demonstrate that these extracts are not inferior    when compared against active comparators, although    this point is a bit more controversial as there are    other published clinical trials that are not conclusive of    such superiority.    &#149; Currently available treatments for the treatment of depression    present some limitations not only in what refers    to their efficacy but also, and mainly, in what refers    to their safety profile, which is not always well accepted.    Within this context, the introduction of new therapeutic    alternatives with a better safety profile, as suggested    with hypericum, would be of great use. The fundamental    problem of hypericum is its multiple pharmacological    interactions. The Eupean Medical Evaluation    Agency (EMEA) recommends not using hypericum concomitantly    with antiretroviral drugs (protease inhibitors),    digoxin, warfarin, cyclosporin, oral contraceptives    and teofiline</dc:description>
<dc:creator>Sancho López, Arantxa</dc:creator>
<dc:creator>Serrano Ruiz, Alfredo</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Hypericum perforatum o hierba de San Juan se utilizó    incialmente como antiinflamatorio (AI) en afecciones    dérmicas. En la actualidad tiene múltiples usos (antidepresivo,    tratamiento del insomnio, ansiolítico, antiinflamatorio,    etc.), no todos oficialmente aceptados.    &#149; Respecto a la eficacia, existen ensayos clínicos publicados    en los que se evidencia la superioridad frente a placebo    de algunos extractos de hypericum en el tratamiento    a corto plazo de la depresión leve a moderada.    Otros ensayos también demuestran la no inferioridad    de estos extractos frente a comparadores activos, aunque    en otros no puede concluirse sobre dicha superioridad.    &#149; Los tratamientos actualmente disponibles para el tratamiento    de la depresión presentan algunas limitaciones,    no sólo en lo relativo a su eficacia sino en lo relacionado    con su perfil de seguridad, el cual no siempre es    bien aceptado. El problema fundamental del hypericum    son sus múltiples interacciones farmacológicas. La    Agencia Europea de Evaluación de Medicamentos    (EMEA) recomienda evitar el uso concomitante de hypericum    junto con antirretrovirales (inhibidores de la    proteasa), digoxina, warfarina, ciclosporina, anticonceptivos    orales y teofilina</dc:description>
<dc:source>Metas enferm;8(2): 59-61, mar. 2005.</dc:source>
<dc:identifier>ibc-036748</dc:identifier>
<dc:title xml:lang="es">Hypericum perforatum: ¿una hierba más?</dc:title>
<dc:subject>^d3883^s22057</dc:subject>
<dc:subject>^d11379</dc:subject>
<dc:subject>^d34154</dc:subject>
<dc:subject>^d8682</dc:subject>
<dc:type>article</dc:type>
<dc:date>200503</dc:date>
</metadata>
</record>
</ibecs-document>
